Why the study?
Does impaired global right ventricular longitudinal strain predict adverse clinical events in patients with pulmonary arterial hypertension?
Population
51 consecutive patients with pulmonary arterial hypertension without atrial fibrillation, mean age 48 ± 14…
Design
Cohort
Follow-up
45 ± 15 months
Authors
Loading...
May aid PAH risk stratification; leaves open whether GLSRV-guided decisions improve outcomes.
Does impaired global right ventricular longitudinal strain predict adverse clinical events in patients with pulmonary arterial hypertension?
Impaired global right ventricular longitudinal strain (≥ -15.5%) measured by 2D strain echocardiography is a strong independent predictor of adverse clinical events and mortality in patients with pulmonary arterial hypertension.
Park et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: